Sorrento Therape Stock Cash Per Share
| SRNE Stock | USD 0 0.0005 16.67% |
Sorrento Therape fundamentals help investors to digest information that contributes to Sorrento Therape's financial success or failures. It also enables traders to predict the movement of Sorrento OTC Stock. The fundamental analysis module provides a way to measure Sorrento Therape's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sorrento Therape otc stock.
Sorrento |
Sorrento Therape OTC Stock Cash Per Share Analysis
Sorrento Therape's Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Current Sorrento Therape Cash Per Share | 0.30 X |
Most of Sorrento Therape's fundamental indicators, such as Cash Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sorrento Therape is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
| Competition |
In accordance with the recently published financial statements, Sorrento Therape has a Cash Per Share of 0.3 times. This is 93.1% lower than that of the Biotechnology sector and 93.07% lower than that of the Health Care industry. The cash per share for all United States stocks is 94.01% higher than that of the company.
Sorrento Cash Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sorrento Therape's direct or indirect competition against its Cash Per Share to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Sorrento Therape could also be used in its relative valuation, which is a method of valuing Sorrento Therape by comparing valuation metrics of similar companies.Sorrento Therape is currently under evaluation in cash per share category among its peers.
Sorrento Fundamentals
| Return On Equity | -3.79 | |||
| Return On Asset | -0.41 | |||
| Operating Margin | (5.11) % | |||
| Current Valuation | 129.17 M | |||
| Shares Outstanding | 551.28 M | |||
| Shares Owned By Insiders | 0.80 % | |||
| Shares Owned By Institutions | 0.03 % | |||
| Number Of Shares Shorted | 64.56 M | |||
| Price To Earning | 41.15 X | |||
| Price To Book | 4.01 X | |||
| Price To Sales | 0.03 X | |||
| Revenue | 62.84 M | |||
| Gross Profit | (167.05 M) | |||
| EBITDA | (364.52 M) | |||
| Net Income | (577.76 M) | |||
| Cash And Equivalents | 133.6 M | |||
| Cash Per Share | 0.30 X | |||
| Total Debt | 134.5 M | |||
| Debt To Equity | 1.51 % | |||
| Current Ratio | 1.35 X | |||
| Book Value Per Share | (0.38) X | |||
| Cash Flow From Operations | (293.86 M) | |||
| Short Ratio | 4.96 X | |||
| Earnings Per Share | (1.10) X | |||
| Price To Earnings To Growth | (0.07) X | |||
| Target Price | 13.0 | |||
| Number Of Employees | 949 | |||
| Beta | 1.84 | |||
| Market Capitalization | 2.21 M | |||
| Total Asset | 472.84 M | |||
| Retained Earnings | (1.96 B) | |||
| Working Capital | (231.55 M) | |||
| Current Asset | 71.84 M | |||
| Current Liabilities | 36.04 M | |||
| Net Asset | 472.84 M |
About Sorrento Therape Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sorrento Therape's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sorrento Therape using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sorrento Therape based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Sorrento OTC Stock
Sorrento Therape financial ratios help investors to determine whether Sorrento OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sorrento with respect to the benefits of owning Sorrento Therape security.